ALX Oncology Holdings Inc. (ALXO) shares outstanding

Shares outstanding · fiscal 2025
53.66M

ALX Oncology Holdings Inc. (ALXO) had 53.66M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.8% higher than the 52.17M of fiscal 2024. Figures as of 18 Nov 2026, 12:33 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
53.66M
Change on fiscal 2024
+2.8%
Growth, 5 years
+23.8% a year
Highest on record
53.66Mfiscal 2025
Lowest on record
2.75Mfiscal 2018
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

ALX Oncology Holdings Inc. shares outstanding, in more detail

The market data feed counts 138.28M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 23.8% a year. Across the 8 fiscal years on record (2018–2025), the highest was 53.66M in fiscal 2025 and the lowest 2.75M in fiscal 2018.

History · 8 fiscal years

Shares outstanding by fiscal year

ALX Oncology Holdings Inc. shares outstanding, year by year

ALX Oncology Holdings Inc. (ALXO) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202553.66M 2.8% up
202452.17M 21.4% up
202342.99M 5.6% up
202240.70M 1.0% up
202140.31M 118.1% up
202018.49M 500.9% up
20193.08M 11.8% up
20182.75M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

More on ALXO

ALX Oncology Holdings Inc., figure by figure

ALX Oncology Holdings Inc. (ALXO) overview: price, valuation and scorecard

ALX Oncology Holdings Inc. shares outstanding: questions and answers

How many shares does ALX Oncology Holdings Inc. have?

ALX Oncology Holdings Inc. (ALXO) had 53.66M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 2.8% higher than the 52.17M of fiscal 2024. The market data feed counts 138.28M shares outstanding today.

What is the growth rate of ALX Oncology Holdings Inc.'s diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 23.8% a year.

What are the highest and lowest diluted share count figures on record for ALX Oncology Holdings Inc.?

Across the 8 fiscal years on record (2018–2025), the highest was 53.66M in fiscal 2025 and the lowest 2.75M in fiscal 2018.

How is ALX Oncology Holdings Inc.'s diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For ALX Oncology Holdings Inc. it is on record here for 8 fiscal years, 2018 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ALX Oncology Holdings Inc. (ALXO) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/ALXO/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.